New drug VOY-101 aims to slow vision loss in dry AMD
Disease control
Recruiting now
This study tests a new drug called VOY-101 in 60 people aged 60 and older with advanced dry age-related macular degeneration (AMD), a condition that causes blind spots. The goal is to see if the drug is safe and can slow the growth of these spots and preserve vision. Participants…
Phase: PHASE1, PHASE2 • Sponsor: Perceive Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:26 UTC